clinical_trials
GLP-1s' Effects on Cancer Risk May Be Influenced by Diabetes Severity
Confidence86·multiple reportsImportance88NP-EVT-20261105-E18AD95
(MedPage Today) -- Diabetic patients treated with GLP-1 receptor agonists had a lower cancer risk versus insulin and sulfonylureas but not other diabetes medications, although the benefits varied by diabetes severity, a large cohort analysis with...
Read the original at the primary source
GLP-1s' Effects on Cancer Risk May Be Influenced by Diabetes Severity
11/5/2026, 6:27:54 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —